DUPIXENT reduced polyp burden as early as Week 4 (LSM difference vs placebo: -1.15 [95% CI: -1.40, -0.91]) in SINUS-52.6

In the same study, patients saw a significant reduction in the size of nasal polyps, as measured by NPS:

Nasal polyp score (NPS) is the sum of right and left nostril scores (range 0 to 8) as evaluated by nasal endoscopy: reduced score indicates improvement.

INCS, intranasal corticosteroid; LSM, least squares mean; Q2W, once every 2 weeks.

See what polyp reduction looks like with DUPIXENT